Pro-inflammatory enzymes and mediators in inflammatory cells

Pro-inflammatory enzymes and mediators in inflammatory cells represent a heterogeneous group of molecules that orchestrate the body's response to harmful stimuli. This category includes enzymes like cyclooxygenase-2 (COX-2), which produces prostaglandins, and cytokines such as tumor necrosis factor-alpha (TNF-alpha) and various interleukins (StatPearls, 2023). These molecules are primarily secreted by activated immune cells like macrophages, lymphocytes, and neutrophils to promote vasodilation, increase vascular permeability, and recruit additional leukocytes to the site of injury (NCBI, 2022). While vital for acute host defense, the persistent activation of these pathways leads to chronic inflammatory and autoimmune disorders. Therapeutic strategies often involve the use of small molecule inhibitors or biologics to suppress specific mediators, thereby reducing tissue damage and systemic symptoms (PubMed, 2021). This term is a functional classification rather than a single molecular target, encompassing a wide range of pharmacological points of intervention across various molecular families.

Other names

Inflammatory mediatorsPro-inflammatory factorsInflammatory enzymesInflammatory signaling moleculesInflammatory cytokines and enzymes

Inhibition of enzymatic activity (e.g., COX-2), neutralization of circulating cytokines (e.g., TNF-alpha), antagonism of cell-surface receptors (e.g., CysLT1), or modulation of inflammatory gene transcription via nuclear receptors.